Moleculin Biotech, Inc. (MBRX) — 分析师展望 / 分析师共识目标价为. 基于 4 位分析师评级, 共识为 看涨 — 4 买入.
分析师预估 每股收益(EPS)为 $-190.08 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-6.32 vs 预期 $-190.08 (超预期 +96.7%). 2025: 实际 $-28.42 vs 预期 $-36.35 (超预期 +21.8%). 分析师准确度: 0%.
MBRX 分析师评级
Buy
基于过去3个月内 4 位分析师对 Moleculin Biotech, Inc. 的评级
EPS 预测 — MBRX
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$6.32
vs Est –$190.08
▲ 2,907.6% off
2025
Actual –$28.42
vs Est –$36.35
▲ 27.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — MBRX
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
